Showing results (21-30 of 125) with videos related to
Sort By:
Pageof 13
American Journal of Clinical Pathology|September 15, 2004
Expression of activated TrkA protein in melanocytic tumors: relationship to cell proliferation and clinical outcomeVivi Ann Flørenes, Gunhild M Maelandsmo, Ruth Holm, et al.Biochimie|September 8, 2015
Nuclear cathepsin L activity is required for cell cycle progression of colorectal carcinoma cellsTripti Tamhane, Rukshala Lllukkumbura, Shiying Lu, et al.The Journal of Surgical Research|August 9, 2005
Matrix metalloproteinases participate in osteosarcoma invasionKristin Bjørnland, Kjersti Flatmark, Solveig Pettersen, et al.Scientific Reports|April 7, 2019
O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer SubtypesAnna Barkovskaya, Kotryna Seip, Bylgja Hilmarsdottir, et al.Oncogene|August 15, 2003
Amplification and overexpression of COPS3 in osteosarcomas potentially target TP53 for proteasome-mediated degradationJørn Henriksen, Trude H Aagesen, Gunhild M Maelandsmo, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 11, 2004
Expression of S100A4 combined with reduced E-cadherin expression predicts patient outcome in malignant melanomaKristin Andersen, Jahn M Nesland, Ruth Holm, et al.Data in Brief|November 24, 2015
Construction of a plasmid coding for green fluorescent protein tagged cathepsin L and data on expression in colorectal carcinoma cellsTripti Tamhane, Brit K Wolters, Rukshala Illukkumbura, et al.Archiv Der Pharmazie|August 16, 2019
Design, synthesis and biological evaluation of 6-substituted quinolines derived from cabozantinib as c-Met inhibitorsVegard Torp Lien, Solveig Pettersen, Mads Haugland Haugen, et al.International Journal of Cancer|July 10, 2009
Biological effects induced by insulin-like growth factor binding protein 3 (IGFBP-3) in malignant melanomaGeir Frode Oy, Ana Slipicevic, Ben Davidson, et al.Molecular Aspects of Medicine|November 10, 2019
Cell-free DNA in blood as a noninvasive insight into the sarcoma genomeHeidi Maria Namløs, Kjetil Boye, Leonardo A Meza-ZepedaPageof 13